Literature DB >> 2261077

[Antiarrhythmic effect of Oenanthe javanica (Bl.) DC. injection].

G Ji1, X Yao, Z Zang, Z Huang.   

Abstract

The antiarrhythmic effect of Shuiqin (Oenanthe javanica) injection was studied in rats. An injection of 3 ml/kg iv could significantly antagonize the arrhythmias induced by aconitine and BaCl2, and decrease the rates of ventricular fibrillation and death induced by CaCl2. The results suggest that Shuqin injection has a significant antiarrhythmic effect on experimental rats.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2261077

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN： 1001-5302


  5 in total

1.  De novo transcriptome assembly, gene annotation, marker development, and miRNA potential target genes validation under abiotic stresses in Oenanthe javanica.

Authors:  Qian Jiang; Feng Wang; Hua-Wei Tan; Meng-Yao Li; Zhi-Sheng Xu; Guo-Fei Tan; Ai-Sheng Xiong
Journal:  Mol Genet Genomics       Date:  2014-11-22       Impact factor: 3.291

2.  Selection of suitable reference genes for qPCR normalization under abiotic stresses in Oenanthe javanica (BI.) DC.

Authors:  Qian Jiang; Feng Wang; Meng-Yao Li; Jing Ma; Guo-Fei Tan; Ai-Sheng Xiong
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

3.  Persicarin isolated from Oenanthe javanica protects against diabetes-induced oxidative stress and inflammation in the liver of streptozotocin-induced type 1 diabetic mice.

Authors:  Joo Young Lee; Min Yeong Kim; Sung Ho Shin; Mi-Rae Shin; O Jun Kwon; Tae Hoon Kim; Chan Hum Park; Jeong Sook Noh; Man Hee Rhee; Seong-Soo Roh
Journal:  Exp Ther Med       Date:  2017-02-10       Impact factor: 2.447

Review 4.  Nutraceutical Compounds Targeting Inflammasomes in Human Diseases.

Authors:  Beatriz Castejón-Vega; Francesca Giampieri; José M Alvarez-Suarez
Journal:  Int J Mol Sci       Date:  2020-07-08       Impact factor: 5.923

Review 5.  A Review of Oenanthe javanica (Blume) DC. as Traditional Medicinal Plant and Its Therapeutic Potential.

Authors:  Chuan-Li Lu; Xiu-Fen Li
Journal:  Evid Based Complement Alternat Med       Date:  2019-04-01       Impact factor: 2.629
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.